Etamicastat - Bial
Alternative Names: BIA-5453Latest Information Update: 27 Dec 2019
At a glance
- Originator Bial
- Developer BIAL
- Class Amines; Antihypertensives; Chromans; Fluorinated hydrocarbons; Heart failure therapies; Imidazoles; Small molecules; Thiones
- Mechanism of Action Dopamine beta-hydroxylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Heart failure; Hypertension
Most Recent Events
- 16 Nov 2019 Pharmacodynamics data from a preclinical study in Hypertension presented at the American Heart Association Scientific Sessions (AHA-2019)
- 01 Aug 2016 Discontinued - Phase-I for Heart failure (In volunteers) in Portugal and France (PO)
- 01 Aug 2016 Discontinued - Phase-I for Hypertension (In volunteers) in Portugal (PO)